Speak to a
    2.5 iPAAG expert

    Contura | Hydrogels for life
    • OUR Technology
      • Our Science
      • Our Facility
    • Our Therapeutic areas
      • Orthopaedics
      • Urinary Incontinence
      • Veterinary Orthopaedics
      • Veterinary Urinary Incontinence
    • Our Story
      • About Us
      • History
      • Team
    • Contact us
    • Careers

    Author: Frederik Steen Jensen

    Speciality European Pharma licenses distribution rights for Cystistat in Germany and France

    Posted on 1 July 2015 | by Frederik Steen Jensen | Leave a Comment on Speciality European Pharma licenses distribution rights for Cystistat in Germany and France

    Contura sells veterinary rights to Antematter

    Posted on 30 December 2014 | by Frederik Steen Jensen | Leave a Comment on Contura sells veterinary rights to Antematter

    Contura terminates Bulkamid distribution rights with Ethicon

    Posted on 3 May 2013 | by Frederik Steen Jensen | Leave a Comment on Contura terminates Bulkamid distribution rights with Ethicon

    Speciality European Pharma acquires Contura A/S

    Posted on 30 April 2013 | by Frederik Steen Jensen | 1 Comment on Speciality European Pharma acquires Contura A/S

    Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

    Posts navigation

    Newer posts

    Recent Posts

    • New study aims to explore further and determine more clearly how a pioneering treatment for knee osteoarthritis works in the NHS
    • First clinician in Wales to offer innovative injection to help patients suffering from knee osteoarthritis
    • Contura Orthopaedics Ltd joins the International Cartilage Regeneration & Joint Preservation Society as its newest industry partner
    • First clinic in Scotland to offer innovative injection to help patients suffering from knee osteoarthritis
    • BASK-ing-IN-THE-GLORY-OF-SUCCESSFUL-SEMINAR-AT-LEADING-ORTHOPAEDIC-CONFERENCE-WITH-PATIENT-OUTCOMES-AT-ITS-HEART.pdf

    Recent Comments

    • A WordPress Commenter on Speciality European Pharma acquires Contura A/S

    Archives

    • September 2023
    • August 2023
    • June 2023
    • April 2023
    • December 2022
    • October 2022
    • November 2021
    • February 2021
    • January 2021
    • February 2020
    • January 2020
    • December 2019
    • October 2019
    • June 2019
    • May 2018
    • January 2018
    • July 2017
    • April 2017
    • February 2017
    • December 2016
    • May 2016
    • September 2015
    • July 2015
    • December 2014
    • May 2013
    • April 2013

    Categories

    • Arthramid Vet
    • Arthrosamid
    • Bulkamid
    • Contura

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    *2.5 iPAAG is an injectable polyacrylamide hydrogel known for its unique
    composition, comprising of 2.5% cross-linked polyacrylamide and 97.5% water.

    Arthrosamid is a registered trademark of Contura International A/S.
    Contura Vet is a registered trademark of Contura Vet Ltd.
    Privacy Notice
    © copyright 2026 Contura International Ltd.

    We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

    I accept My Preferences